Postgrafting immunosuppression with sirolimus and cyclosporine facilitates stable mixed hematopoietic chimerism in dogs given sublethal total body irradiation before marrow transplantation from DLA-identical littermates

Biology of Blood and Marrow Transplantation

Volumn 9, Issue 8, 2003, Pages 489-495

  Hogan, William J ^a   Little, Marie Térèse ^a   Zellmer, Eustacia ^a   Friedetzky, Anke ^a   Diaconescu, Razvan ^a   Gisburne, Serina ^a   Lee, Richard ^b   Kuhr, Christian ^b   Storb, Rainer ^a,b  

^a Fred Hutchinson Cancer Research Center   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

Engraftment; Graft rejection; Hematopoietic cell transplantation

Indexed keywords

CYCLOSPORIN; HLA ANTIGEN; METHOTREXATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; RAPAMYCIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE MARROW TRANSPLANTATION; CAUSE OF DEATH; COHORT ANALYSIS; CONTROLLED STUDY; DOG; DONOR; FOLLOW UP; GRAFT REJECTION; HEMATOPOIETIC CELL; HISTOCOMPATIBILITY; HLA MATCHING; IMMUNOSUPPRESSIVE TREATMENT; NONHUMAN; OUTCOMES RESEARCH; PNEUMONIA; RADIATION DOSE; SKIN GRAFT; TANDEM REPEAT; TRANSPLANTATION TOLERANCE; WHOLE BODY RADIATION;

ANIMALS; BONE MARROW TRANSPLANTATION; CYCLOSPORINE; DOGS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG THERAPY, COMBINATION; GRAFT SURVIVAL; HISTOCOMPATIBILITY ANTIGENS; IMMUNOSUPPRESSION; KINETICS; LEUKOCYTES; LIVER FUNCTION TESTS; SIROLIMUS; TRANSPLANTATION CHIMERA; TREATMENT OUTCOME; WHOLE-BODY IRRADIATION;

EID: 0346363060     PISSN: 10838791     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1083-8791(03)00148-4     Document Type: Article

References (18)

1. Storb R. Yu C. Wagner J.L. et al. Stable mixed hematopoietic chimerism in DLA-identical littermate dogs given sublethal total body irradiation before and pharmacological immunosuppression after marrow transplantation Blood 89 1997 3048-3054
2. Storb R. Deeg H.J. Raff R. et al. Prevention of graft-versus-host disease: studies in a canine model [Review] Ann N Y Acad Sci 770 1995 149-164
3. Kahan B.D. Chang J.Y. Sehgal S.N. Preclinical evaluation of a new potent immunosuppressive agent, rapamycin Transplantation 52 1991 185-191
4. Kahan B.D. Sirolimus: a comprehensive review [Review] Expert Opinion on Pharmacotherapy 2 2001 1903-1917
5. Kimball P.M. Kerman R.H. Kahan B.D. Production of synergistic but nonidentical mechanisms of immunosuppression by rapamycin and cyclosporine Transplantation 51 1991 486-490
6. Kahan B.D. Gibbons S. Tejpal N. Stepkowski S.M. Chou T.C. Syngergistic interactions of cyclosporine and rapamycin to inhibit immune performances of normal human peripheral blood lymphocytes in vitro Transplantation 51 1991 232-239
7. Wagner J.L. Burnett R.C. DeRose S.A. Francisco L.V. Storb R. Ostrander E.A. Histocompatibility testing of dog families with highly polymorphic microsatellite markers Transplantation 62 1996 876-877
8. Burnett R.C. Francisco L.V. DeRose S.A. Storb R. Ostrander E.A. Identification and characterization of a highly polymorphic microsatellite marker within the canine MHC class I region Mamm Genome 6 1995 684-685
9. Wagner J.L. Works J.D. Storb R. DLA-DRB1 and DLA-DQB1 histocompatibility typing by PCR-SSCP and sequencing [Brief Communication] Tissue Antigens 52 1998 397-401
10. Yu C. Ostrander E. Bryant E. Burnett R. Storb R. Use of (CA)n polymorphisms to determine the origin of blood cells after allogeneic canine marrow grafting Transplantation 58 1994 701-706
11. Schroeder M.L. Storb R. Graham T.C. Weiden P.L. Canine radiation chimeras: an attempt to demonstrate serum blocking factors by an in vivo approach J Immunol 114 1975 540-541
12. Ochs H.D. Storb R. Thomas E.D. et al. Immunologic reactivity in canine marrow graft recipients J Immunol 113 1974 1039-1057
13. Calne R.Y. Collier D.S. Lim S. et al. Rapamycin for immunosuppression in organ allografting [Letter] Lancet 2 1989 227 -
14. Abraham R.T. Wiederrecht G.J. Immunopharmacology of rapamycin [Review] Annu Rev Immunol 14 1996 483-510
15. Woltman A.M. Van Der Kooij S.W. Coffer P.J. Offringa R. Daha M.R. van Kooten C. Rapamycin specifically interferes with GM-CSF signaling in human dendritic cells, leading to apoptosis via increased p27KIP1 expression Blood 101 2003 1439-1445
16. Woltman A.M. de Fijter J.W. Kamerling S.W. et al. Rapamycin induces apoptosis in monocyte- and CD34-derived dendritic cells but not in monocytes and macrophages Blood 98 2001 174-180
17. Grolleau A. Bowman J. Pradet-Balade B. et al. Global and specific translational control by rapamycin in T cells uncovered by microarrays and proteomics J Biol Chem 277 2002 22175-22184
18. Ghosh P. Buchholz M.A. Yano S. Taub D. Longo D.L. Effect of rapamycin on the cyclosporin A-resistant CD28-mediated costimulatory pathway Blood 99 2002 4517-4524